This year, the biotech expects the results of a test of Jakafi in a group of chronic graft vs. host disease patients, she said in an email.Coronavirus Test Maker Soars As Its Diagnostic Proves 100% Accurate Run Custom Stock Screens With MarketSmith Want More IBD Insights?